Preclinical Data Demonstrate Sotrovimab Retains Activity Against Key Omicron Mutations, New SARS-CoV-2 Variant
Go back to Preclinical Data Demonstrate Sotrovimab Retains Activity Against Key Omicron Mutations, New SARS-CoV-2 Variant| (NASDAQ: VIR) | Delayed: 10.73 +0.16 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.57 | 52 Week High | $ | |||
| Open | $10.60 | 52 Week Low | $ | |||
| Day High | $10.73 | P/E | N/A | |||
| Day Low | $10.60 | EPS | $ | |||
| Volume | 50,835 | |||||



